跨学科人类基因编辑研究的策略:来自瑞士项目的见解。

IF 4 4区 生物学 Q2 GENETICS & HEREDITY
CRISPR Journal Pub Date : 2025-04-01 Epub Date: 2025-04-02 DOI:10.1089/crispr.2024.0041
Agnes Kandlbinder, Marie-Hélène Peter-Spiess, Brigitte Leeners, Amina Mollaysa, Tommaso Cavazza, Anina Meier, Michael Braunschweig, Eleonora Ioannidi, Gerald Schwank, Michael Krauthammer
{"title":"跨学科人类基因编辑研究的策略:来自瑞士项目的见解。","authors":"Agnes Kandlbinder, Marie-Hélène Peter-Spiess, Brigitte Leeners, Amina Mollaysa, Tommaso Cavazza, Anina Meier, Michael Braunschweig, Eleonora Ioannidi, Gerald Schwank, Michael Krauthammer","doi":"10.1089/crispr.2024.0041","DOIUrl":null,"url":null,"abstract":"<p><p>CRISPR gene editing is a cutting-edge technology that has advanced tremendously in recent years. The first clinical CRISPR applications have been approved, and more gene editing therapies are to be expected in human medicine. Consequently, continuous basic research is needed to assess possibilities and prime future clinical applications. Because this technology not only offers new possibilities for treating diseases but also raises important ethical and societal questions, collaboration between human, life, biomedical, and medical sciences is needed. In this article, we discuss the practical challenges of such interdisciplinary projects and present strategies for addressing them based on our experience of conducting an interdisciplinary project on CRISPR. This work aims to help and encourage interdisciplinary collaborations and discussions on modern scientific endeavors that, such as gene editing, tend to blur the lines between traditional disciplines. The strategies suggested include realistic expectations, shared goals, space setting, and expert and lay dialogue.</p>","PeriodicalId":54232,"journal":{"name":"CRISPR Journal","volume":" ","pages":"79-88"},"PeriodicalIF":4.0000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7617730/pdf/","citationCount":"0","resultStr":"{\"title\":\"Strategies for Interdisciplinary Human Gene Editing Research: Insights from a Swiss Project.\",\"authors\":\"Agnes Kandlbinder, Marie-Hélène Peter-Spiess, Brigitte Leeners, Amina Mollaysa, Tommaso Cavazza, Anina Meier, Michael Braunschweig, Eleonora Ioannidi, Gerald Schwank, Michael Krauthammer\",\"doi\":\"10.1089/crispr.2024.0041\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>CRISPR gene editing is a cutting-edge technology that has advanced tremendously in recent years. The first clinical CRISPR applications have been approved, and more gene editing therapies are to be expected in human medicine. Consequently, continuous basic research is needed to assess possibilities and prime future clinical applications. Because this technology not only offers new possibilities for treating diseases but also raises important ethical and societal questions, collaboration between human, life, biomedical, and medical sciences is needed. In this article, we discuss the practical challenges of such interdisciplinary projects and present strategies for addressing them based on our experience of conducting an interdisciplinary project on CRISPR. This work aims to help and encourage interdisciplinary collaborations and discussions on modern scientific endeavors that, such as gene editing, tend to blur the lines between traditional disciplines. The strategies suggested include realistic expectations, shared goals, space setting, and expert and lay dialogue.</p>\",\"PeriodicalId\":54232,\"journal\":{\"name\":\"CRISPR Journal\",\"volume\":\" \",\"pages\":\"79-88\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7617730/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CRISPR Journal\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1089/crispr.2024.0041\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CRISPR Journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/crispr.2024.0041","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

摘要

CRISPR基因编辑是近年来取得巨大进步的一项尖端技术。CRISPR的首个临床应用已经获得批准,更多的基因编辑疗法有望应用于人类医学。因此,需要持续的基础研究来评估可能性和确定未来的临床应用。由于这项技术不仅为治疗疾病提供了新的可能性,而且也提出了重要的伦理和社会问题,因此需要人类、生命、生物医学和医学科学之间的合作。在本文中,我们讨论了此类跨学科项目的实际挑战,并根据我们开展CRISPR跨学科项目的经验提出了解决这些挑战的策略。这项工作旨在帮助和鼓励现代科学努力的跨学科合作和讨论,比如基因编辑,这些努力往往模糊了传统学科之间的界限。建议的策略包括现实的期望、共同的目标、空间设置以及专家和非专业人士的对话。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Strategies for Interdisciplinary Human Gene Editing Research: Insights from a Swiss Project.

CRISPR gene editing is a cutting-edge technology that has advanced tremendously in recent years. The first clinical CRISPR applications have been approved, and more gene editing therapies are to be expected in human medicine. Consequently, continuous basic research is needed to assess possibilities and prime future clinical applications. Because this technology not only offers new possibilities for treating diseases but also raises important ethical and societal questions, collaboration between human, life, biomedical, and medical sciences is needed. In this article, we discuss the practical challenges of such interdisciplinary projects and present strategies for addressing them based on our experience of conducting an interdisciplinary project on CRISPR. This work aims to help and encourage interdisciplinary collaborations and discussions on modern scientific endeavors that, such as gene editing, tend to blur the lines between traditional disciplines. The strategies suggested include realistic expectations, shared goals, space setting, and expert and lay dialogue.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CRISPR Journal
CRISPR Journal Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
6.30
自引率
2.70%
发文量
76
期刊介绍: In recognition of this extraordinary scientific and technological era, Mary Ann Liebert, Inc., publishers recently announced the creation of The CRISPR Journal -- an international, multidisciplinary peer-reviewed journal publishing outstanding research on the myriad applications and underlying technology of CRISPR. Debuting in 2018, The CRISPR Journal will be published online and in print with flexible open access options, providing a high-profile venue for groundbreaking research, as well as lively and provocative commentary, analysis, and debate. The CRISPR Journal adds an exciting and dynamic component to the Mary Ann Liebert, Inc. portfolio, which includes GEN (Genetic Engineering & Biotechnology News) and more than 80 leading peer-reviewed journals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信